GLIOBLASTOM WHO GRADE 4
Clinical trials for GLIOBLASTOM WHO GRADE 4 explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOM WHO GRADE 4 trials appear
Sign up with your email to follow new studies for GLIOBLASTOM WHO GRADE 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation zaps glioblastoma cells after surgery
Disease control OngoingThis early-phase trial tests a new treatment for glioblastoma, an aggressive brain cancer. After standard therapy (surgery, chemo, radiation), a radioactive antibody is injected into the brain cavity to target remaining tumor cells and delay recurrence. The study enrolls 15 adult…
Matched conditions: GLIOBLASTOM WHO GRADE 4
Phase: PHASE1 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
MRNA vaccines take on glioblastoma: a new hope against brain cancer recurrence?
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests two mRNA vaccines, GV-907 and GV-108, in 9 adults with a specific type of glioblastoma. The goal is to see if the vaccines are safe and can trigger an immune response to prevent the cancer from coming back after standard treatment.
Matched conditions: GLIOBLASTOM WHO GRADE 4
Phase: EARLY_PHASE1 • Sponsor: Beijing Neurosurgical Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC